Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07020559 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial

StatusNot Yet Recruiting
PhasePhase 4
Started2026-04
View on ClinicalTrials.gov ↗

Amendment history

2025-08-23
Study Status v2
Primary completion date2027-09→2027-12
Start date2025-10→2026-04
2025-07-23
Study Status, Study Description v1
Primary completion date2027-12→2027-09
Study description+39 characters
[...] The secondary outcomes include the wound healing rates at 3 weeks, 6the reduction rate of wound area at 2-, 3- and 84- weeks, healing time, post-operative wound infection, 7-day, 2-, 3-, 4-, 6-, 8-week pain relief progression assessed by Visual Analog Scal [...]
2025-06-06
Original filing
Diabetic wounds are difficult to heal. Autologous platelets in diabetic patients with renal insufficiency have poor function. Allogeneic platelet plasma has a promising application prospect. Comparing the efficacy and safety differences between allogeneic platelet plasma and autologous platelet plasma is of significant importance and value for the clinical application.
Trial Details
NCT Number NCT07020559
Lead Sponsor Peking University Third Hospital
Conditions Diabetic Wounds, Platelet Rich Plasma, Allogeneic Blood Transfusions, Renal Dysfunction
Enrollment 56 participants
Start Date 2026-04
Primary Completion 2027-12 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-26